89 related articles for article (PubMed ID: 12620999)
1. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.
Ryu SY; Kim MH; Choi SC; Choi CW; Lee KH
J Nucl Med; 2003 Mar; 44(3):347-52. PubMed ID: 12620999
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of FIGO staging defined by combining MRI and [
Raffa S; Lanfranchi F; Satragno C; Giannelli F; Marcenaro M; Coco A; Cena SE; Sofia L; Marini C; Mammoliti S; Levaggi A; Tagliafico AS; Sambuceti G; Barra S; Morbelli S; Belgioia L; Bauckneht M
Curr Probl Cancer; 2023 Dec; 47(6):101007. PubMed ID: 37684197
[TBL] [Abstract][Full Text] [Related]
3. Use of positron emission tomography in surgery follow-up of esophageal cancer.
Teyton P; Metges JP; Atmani A; Jestin-Le Tallec V; Volant A; Visvikis D; Bail JP; Pradier O; Lozac'h P; Cheze Le Rest C
J Gastrointest Surg; 2009 Mar; 13(3):451-8. PubMed ID: 19023632
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of MRI, CT, and [
Olthof EP; Bergink-Voorthuis BJ; Wenzel HHB; Mongula J; van der Velden J; Spijkerboer AM; Adam JA; Bekkers RLM; Beltman JJ; Slangen BFM; Nijman HW; Smolders RGV; van Trommel NE; Zusterzeel PLM; Zweemer RP; Stalpers LJA; Mom CH; van der Aa MA
Insights Imaging; 2024 Feb; 15(1):36. PubMed ID: 38332397
[TBL] [Abstract][Full Text] [Related]
5. Treatment Strategies Guided by [18F]FDG-PET/CT in Patients with Locally Advanced Cervical Cancer and [18F]FDG-Positive Lymph Nodes.
Olthof EP; Wenzel HHB; van der Velden J; Stalpers LJA; Mom CH; van der Aa MA
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398108
[TBL] [Abstract][Full Text] [Related]
6. Impact of 18 F-FDG PET on the Management in Patients With Recurrent Gynecologic cancer : A Meta-analysis.
Pak K; Yoon HJ
Clin Nucl Med; 2023 Nov; 48(11):945-949. PubMed ID: 37756472
[TBL] [Abstract][Full Text] [Related]
7. Challenges in Pharmacokinetic Modelling of [
Ruytenberg T; Ciggaar IA; Peters ITA; Noortman WA; Dibbets-Schneider P; de Muynck LDAN; Kuil J; de Kroon CD; Molenaar TJM; Helmerhorst HJF; Pereira Arias-Bouda LM; Vahrmeijer AL; Windhorst AD; van Velden FHP; Gaarenstroom KN; de Geus-Oei LF
Mol Imaging Biol; 2024 May; ():. PubMed ID: 38775919
[TBL] [Abstract][Full Text] [Related]
8. Impact of hypoxia on cervical cancer outcomes.
Datta A; West C; O'Connor JPB; Choudhury A; Hoskin P
Int J Gynecol Cancer; 2021 Nov; 31(11):1459-1470. PubMed ID: 34593564
[TBL] [Abstract][Full Text] [Related]
9. Early recurrence detected by [
Fernández-Rodríguez P; Herrera-Martínez Y; Sánchez Matas C; Acevedo Báñez I; Jiménez-Hoyuela García JM
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021 May; ():. PubMed ID: 34083175
[No Abstract] [Full Text] [Related]
10. Correction to: [
Peng L; Liao Y; Zhou R; Zhong Y; Jiang H; Wang J; Fu Y; Xue L; Zhang X; Sun M; Feng G; Meng Z; Peng S; He X; Teng G; Gao X; Zhang H; Tian M
Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3796. PubMed ID: 37610433
[No Abstract] [Full Text] [Related]
11. Editorial Comment: On the Contemporary Role of MRI and FDG PET/CT in Managing Cervical Cancer.
Ghafoor S
AJR Am J Roentgenol; 2023 Nov; 221(5):648. PubMed ID: 37315016
[No Abstract] [Full Text] [Related]
12. [Uterine Cervical Cancer: Emphasis on Revised FIGO Staging 2018 and MRI].
Jang W; Song JS
Taehan Yongsang Uihakhoe Chi; 2021 Sep; 82(5):1083-1102. PubMed ID: 36238389
[TBL] [Abstract][Full Text] [Related]
13. Predictive Role of MRI and
Perrone AM; Dondi G; Coe M; Ferioli M; Telo S; Galuppi A; Crescenzo E; Tesei M; Castellucci P; Nanni C; Fanti S; Morganti AG; De Iaco P
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32178252
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic performance of PET/CT scans for the detection of para-aortic metastatic lymph nodes in patients with cervical cancer: A meta-analysis.
Yu W; Kou C; Bai W; Yu X; Duan R; Zhu B; Li Y; Hua W; Ren X; Yang Y
PLoS One; 2019; 14(7):e0220080. PubMed ID: 31318962
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of PET/CT Detect Lymph Nodes Metastases of Cervical Cancer.
Ruan J; Zhang Y; Ren H
Open Med (Wars); 2018; 13():436-442. PubMed ID: 30263970
[TBL] [Abstract][Full Text] [Related]
16. [18F]-2-Fluoro-2-Deoxy-D-glucose-PET Assessment of Cervical Cancer.
Viswanathan C; Faria S; Devine C; Patnana M; Sagebiel T; Iyer RB; Bhosale PR
PET Clin; 2018 Apr; 13(2):165-177. PubMed ID: 29482748
[TBL] [Abstract][Full Text] [Related]
17. [
Anner P; Mayerhöfer M; Wadsak W; Geleff S; Dudczak R; Haug A; Hacker M; Karanikas G
Oncol Lett; 2018 Mar; 15(3):3951-3956. PubMed ID: 29467905
[TBL] [Abstract][Full Text] [Related]
18. A Network Meta-Analysis on the Diagnostic Value of Different Imaging Methods for Lymph Node Metastases in Patients With Cervical Cancer.
Luo Q; Luo L; Tang L
Technol Cancer Res Treat; 2018 Jan; 17():1533034617742311. PubMed ID: 29343205
[TBL] [Abstract][Full Text] [Related]
19. Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer.
Hu YY; Fan W; Zhang X; Liang PY; Lin XP; Zhang YR; Li YH
J Cancer; 2015; 6(3):287-91. PubMed ID: 25663947
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography alone, positron emission tomography-computed tomography and computed tomography in diagnosing recurrent cervical carcinoma: a systematic review and meta-analysis.
Xiao Y; Wei J; Zhang Y; Xiong W
Arch Med Sci; 2014 May; 10(2):222-31. PubMed ID: 24904653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
